Relevant Articles About DLBCL (Diffuse Large B Cell Lymphoma)
Lymphoma Research and Clinical Trials
Trusted insights straight to your inbox and get the latest updates from OncWeekly
KEY TAKEAWAYS The study aimed to systematically investigate how radiation doses in brain structures correlate with fatigue following H&N RT. The findings suggested that fatigue in patients with H&N RT is related to brain area radiation doses. Radical...
KEY TAKEAWAYS The study aimed to conduct comprehensive genomic analysis of high-grade CFOS using SNP array and targeted NGS. The results showed that the high-grade CFOS exhibit complex genomic alterations, featuring RTK gene amplifications and frequent tumor...
KEY TAKEAWAYS The study aimed to report outcomes from a substantial series of IM treated with curative-intent proton therapy. The study's findings concluded proton therapy effectively treated IM with acceptable toxicity, representing a substantial patient cohort....
The Smart Stop phase 2 study aimed to investigate the efficacy of reducing or omitting CIT cycles after a positive response to targeted …
The phase 2 study aimed to investigate the efficacy of early intervention with Glofitamab plus R-CHOP in improving outcomes for previously untreated high-risk …
The phase 1 & 2 trial aimed to assess the preliminary efficacy and safety of M-Pola in elderly, U/F pts with newly diagnosed …
Chimeric antigen receptor (CAR) T-cell therapy has emerged as a transformative treatment for various hematological malignancies. Still, its remarkable efficacy is accompanied by unique adverse events that must be carefully managed. This comprehensive literature review …
Objectives: Breast cancer is the most diagnosed cancer in women, with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2–) being the predominant subtype. Sacituzumab govitecan (SG), a novel antibody-drug conjugate, has emerged as a promising …
Objectives: For many malignancies, hypofractionated radiotherapy (HFRT) is an accepted standard associated with decreased treatment time and costs. United States provider beliefs regarding HFRT likely impact its adoption but are poorly studied. We surveyed US-based …
Objective: This systematic review and meta-analysis aims to evaluate the efficacy and safety of bevacizumab in patients with ovarian cancer over a shorter and longer follow-up period. Methods: We searched Medline, Cochrane CENTRAL, Scopus, and Google …